These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 15339308)

  • 1. Some unexamined aspects of analysis of covariance in pretest-posttest studies.
    Ganju J
    Biometrics; 2004 Sep; 60(3):829-33. PubMed ID: 15339308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of covariance with pre-treatment measurements in randomized trials: comparison of equal and unequal slopes.
    Funatogawa I; Funatogawa T
    Biom J; 2011 Sep; 53(5):810-21. PubMed ID: 21887795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of covariance (ANCOVA) with difference scores.
    Jamieson J
    Int J Psychophysiol; 2004 May; 52(3):277-83. PubMed ID: 15094250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analytic methods for questions pertaining to a randomized pretest, posttest, follow-up design.
    Rausch JR; Maxwell SE; Kelley K
    J Clin Child Adolesc Psychol; 2003 Sep; 32(3):467-86. PubMed ID: 12881035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parametric versus non-parametric statistics in the analysis of randomized trials with non-normally distributed data.
    Vickers AJ
    BMC Med Res Methodol; 2005 Nov; 5():35. PubMed ID: 16269081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of screening on some pretest-posttest test variances.
    Follmann DA
    Biometrics; 1991 Jun; 47(2):763-71. PubMed ID: 1912270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonparametric analysis of covariance for comparing change in randomized studies with baseline values subject to error.
    Knoke JD
    Biometrics; 1991 Jun; 47(2):523-33. PubMed ID: 1912259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal analysis of pre- and post-treatment measurements with equal baseline assumptions in randomized trials.
    Funatogawa I; Funatogawa T
    Biom J; 2020 Mar; 62(2):350-360. PubMed ID: 31394012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Change from baseline and analysis of covariance revisited.
    Senn S
    Stat Med; 2006 Dec; 25(24):4334-44. PubMed ID: 16921578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A structural equation modelling approach to the analysis of change.
    Tu YK; Baelum V; Gilthorpe MS
    Eur J Oral Sci; 2008 Aug; 116(4):291-6. PubMed ID: 18705795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of covariance with pre-treatment measurements in randomized trials under the cases that covariances and post-treatment variances differ between groups.
    Funatogawa T; Funatogawa I; Shyr Y
    Biom J; 2011 May; 53(3):512-24. PubMed ID: 22223254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of statistical models adjusting for baseline in the analysis of parallel-group thorough QT/QTc studies.
    Sun GG; Quan H; Kringle R; Meng Z
    J Biopharm Stat; 2012; 22(3):438-62. PubMed ID: 22416834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Semi-parametric and non-parametric methods for clinical trials with incomplete data.
    O'Brien PC; Zhang D; Bailey KR
    Stat Med; 2005 Feb; 24(3):341-58. PubMed ID: 15547952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On efficiency of constrained longitudinal data analysis versus longitudinal analysis of covariance.
    Lu K
    Biometrics; 2010 Sep; 66(3):891-6. PubMed ID: 19764951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statistical issues on the analysis of change in follow-up studies in dental research.
    Blance A; Tu YK; Baelum V; Gilthorpe MS
    Community Dent Oral Epidemiol; 2007 Dec; 35(6):412-20. PubMed ID: 18039282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of covariance in parallel-group clinical trials with pretreatment baselines.
    Crager MR
    Biometrics; 1987 Dec; 43(4):895-901. PubMed ID: 3427174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tests for the analysis of variance of crossover designs with correlated errors.
    Bellavance F; Tardif S; Stephens MA
    Biometrics; 1996 Jun; 52(2):607-12. PubMed ID: 8672705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving the estimation of change from baseline in a continuous outcome measure in the clinical trial setting.
    Mayer-Hamblett N; Kronmal RA
    Contemp Clin Trials; 2005 Feb; 26(1):2-16. PubMed ID: 15837448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of the average baseline versus the time-matched baseline in parallel group thorough QT/QTc studies.
    Meng Z; Quan H; Fan L; Kringle R; Sun G
    J Biopharm Stat; 2010 May; 20(3):665-82. PubMed ID: 20358444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A model selection approach to analysis of variance and covariance.
    Alber SA; Weiss RE
    Stat Med; 2009 Jun; 28(13):1821-40. PubMed ID: 19387975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.